The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 227.50
Bid: 226.50
Ask: 228.00
Change: 2.00 (0.89%)
Spread: 1.50 (0.662%)
Open: 228.00
High: 228.50
Low: 224.50
Prev. Close: 225.50
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

12 Oct 2022 07:00

RNS Number : 5334C
PureTech Health PLC
12 October 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BY2Z0H74

Issuer Name

PURETECH HEALTH PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

Other

Comments

'Transaction in own shares'

3. Details of person subject to the notification obligation

Name

Invesco Ltd.

City of registered office (if applicable)

Atlanta

Country of registered office (if applicable)

USA

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

07-Oct-2022

6. Date on which Issuer notified

11-Oct-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

23.039000

0.000000

23.039000

64894725

Position of previous notification (if applicable)

22.503000

0.000000

22.503000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BY2Z0H74

0

64894725

0.000000

23.039000

Sub Total 8.A

64894725

23.039000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Invesco Ltd.

Invesco Asset Management Limited

22.929600

0.000000

22.929600%

Invesco Ltd.

Invesco Capital Management LLC

0.109600

0.000000

0.109600%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Refer to section 9 for detail of proxy holders' and % of voting rights held. Voting authority is held until it is revoked by the client/ the relevant Investment Management Agreement is terminated.

12. Date of Completion

11-Oct-2022

13. Place Of Completion

Henley-on-Thames

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLMBBITMTBBBLT
Date   Source Headline
12th Oct 20227:00 amRNSHolding(s) in Company
12th Oct 20227:00 amRNSTransaction in Own Shares
11th Oct 20222:35 pmRNSForm 8.3 - Nektar Therapeutics Inc
11th Oct 20222:07 pmRNSForm 8.3 - Puretech Health Plc
11th Oct 202210:03 amRNSForm 8.5 (EPT/RI) - PureTech Health plc
11th Oct 20229:49 amRNSForm 8.5 (EPT/RI)- Nektar Therapeutics, Inc
11th Oct 20229:45 amRNSForm 8.5 (EPT/RI)- PureTech Health plc
11th Oct 20229:43 amRNSForm 8.5 (EPT/RI)-PureTech Health plc
11th Oct 20229:01 amRNSForm 8.5 (EPT/NON-RI) Puretech Health Plc
11th Oct 20227:00 amRNSStatement regarding PureTech Health plc
11th Oct 20227:00 amRNSOffer Talks Terminated
11th Oct 20227:00 amRNSTransaction in Own Shares
10th Oct 20223:20 pmRNSForm 8.3 - PureTech Health plc
10th Oct 20223:15 pmGNWForm 8 (OPD) PureTech Health PLC
10th Oct 20222:54 pmRNSForm 8.3 - Nektar Therapeutics Inc
10th Oct 20222:19 pmEQSForm 8.3 - The Vanguard Group, Inc.: PureTech Health plc
10th Oct 20222:03 pmRNSForm 8.3 - Puretech Health Plc
10th Oct 20221:17 pmRNSForm 8.3 - PureTech Health plc
10th Oct 20221:17 pmRNSForm 8.3 - Nektar Therapeutics, Inc.
10th Oct 20221:13 pmRNSForm 8.3 - PureTech Health PLC
10th Oct 202212:57 pmRNSForm 8.3 - Puretech Health Plc
10th Oct 202212:04 pmRNSForm 8.5 (EPT/RI)-PureTech Health plc
10th Oct 202212:00 pmGNWForm 8.3 - [PureTech Health plc - 07 10 2022 - Opening Declaration] - (HHL)
10th Oct 202211:55 amRNSForm 8.5 (EPT/RI)-PureTech Health plc
10th Oct 202211:48 amRNSForm 8.5 (EPT/RI)- PureTech Health plc
10th Oct 202211:44 amRNSForm 8.3 - [PureTech Health plc]
10th Oct 202211:35 amRNSForm 8.5 (EPT/RI) - PureTech Health plc
10th Oct 202211:17 amRNSForm 8.3 - PureTech Health PLC
10th Oct 202211:10 amRNSForm 8.3 - PureTech Health PLC
10th Oct 20229:52 amRNSForm 8.5 (EPT/NON-RI) PureTech Health Plc
10th Oct 20229:45 amRNSForm 8.5 (EPT/NON-RI) PureTech Health Plc
10th Oct 20229:18 amRNSForm 8.5 (EPT/RI)
10th Oct 20227:00 amRNSTransaction in Own Shares
7th Oct 20227:00 amRNSTransaction in Own Shares
7th Oct 20227:00 amRNSStatement re Possible Offer
6th Oct 20227:00 amRNSTransaction in Own Shares
5th Oct 20227:00 amRNSTransaction in Own Shares
4th Oct 20227:00 amRNSTransaction in Own Shares
3rd Oct 20227:00 amRNSTransaction in Own Shares
29th Sep 20227:00 amRNSTransaction in Own Shares
28th Sep 20227:00 amRNSTransaction in Own Shares
27th Sep 20227:00 amRNSTransaction in Own Shares
26th Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20227:00 amRNSTransaction in Own Shares
22nd Sep 20227:00 amRNSTransaction in Own Shares
21st Sep 20227:00 amRNSTransaction in Own Shares
19th Sep 20227:00 amRNSTransaction in Own Shares
16th Sep 20227:00 amRNSTransaction in Own Shares
15th Sep 20227:00 amRNSTransaction in Own Shares
14th Sep 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.